FDA Clears Troubled COVID-19 Vaccine Manufacturer to Resume Production
The company announced the news in a statement late Wednesday.
Saul Loeb/AFP via Getty
The Food and Drug Administration has cleared the manufacturer responsible for contaminating millions of vials of COVID-19 vaccines to resume production at its Baltimore plant. “We are proud to be resuming production of bulk COVID-19 vaccine batches following additional reviews and collaboration with FDA and our manufacturing partners,” Emergent BioSolutions Robert Kramer said in a statement Wednesday, according to The Wall Street Journal. The plant was responsible for contaminating 75 million doses of the Johnson & Johnson and AstraZeneca vaccines at its Baltimore facility, with 30 million J&J doses produced by the plant waiting for FDA clearance. A source told the Journal that the plant could end up making 120 million doses a month of the J&J vaccine, but those vials may not be shipped until the fall. The U.S. has seen a lack of interest in the one-dose treatment, which has been marred by different problems, resulting in it exporting the vials to other countries in need.
See more of our coverage in your search results.
Got a tip? Send it to The Daily Beast here.
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.